The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anderson, J. K., Zimmerman, L., Caplan, L., & Michaud, K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20621 · Cited by 260
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
Burmester, G. R., Rigby, W. F., van Vollenhoven, R. F., Kay, J., Rubbert-Roth, A., Kelman, A., Dimonaco, S., & Mitchell, N. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207628 · Cited by 194
Straub, R. H., Cutolo, M., & Pacifici, R. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.04.014 · Cited by 132 · cited 1×
“Additionally, rapid and sustained control of the acute-phase response might result in a reduction of systemic extra-articular disease manifestations, such as anaemia, 47 osteoporosis, 48 and cardiovascular disease.”
Isaacs, J. D., Harari, O., Kobold, U., Lee, J. S., & Bernasconi, C. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4397 · Cited by 105
Self-citation
Cited by
Smolen, J. S., Landewé, R. B. M., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A., van Vollenhoven, R. F., de Wit, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,710
Self-citationSmolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Self-citationSmolen, J. S., Landewé, R., Breedveld, F. C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204573 · Cited by 1,763
Self-citationNovel treatment strategies in rheumatoid arthritis
Burmester, G. R., & Pope, J. E. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31491-5 · Cited by 1,068
Targeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Metadata
- Authors
- Bijlsma, J. W. J., Welsing, P. M. J., Woodworth, T. G., Middelink, L. M., Pethö-Schramm, A., Bernasconi, C., Borm, M. E. A., Wortel, C. H., ter Borg, E. J., Jahangier, Z. N., van der Laan, W. H., Bruyn, G. A. W., Baudoin, P., Wijngaarden, S., Vos, P. A. J. M., Bos, R., Starmans, M. J. F., Griep, E. N., Griep-Wentink, J. R. M., Allaart, C. F., Heurkens, A. H. M., Teitsma, X. M., Tekstra, J., Marijnissen, A. C. A., Lafeber, F. P. J., & Jacobs, J. W. G.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 388
- Issue
- 10042
- Pages
- 343-355
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2408830150
- Cited by
- 248
- References
- 4
- FWCI
- 29.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial. https://app.cochat.ai/papers/10.1016/s0140-6736(16)30363-4
- The paper
- Bijlsma, J. W. J., Welsing, P. M. J., Woodworth, T. G., Middelink, L. M., Pethö-Schramm, A., Bernasconi, C., Borm, M. E. A., Wortel, C. H., ter Borg, E. J., Jahangier, Z. N., van der Laan, W. H., Bruyn, G. A. W., Baudoin, P., Wijngaarden, S., Vos, P. A. J. M., Bos, R., Starmans, M. J. F., Griep, E. N., Griep-Wentink, J. R. M., . . . Jacobs, J. W. G. (2016). Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial. The Lancet. https://doi.org/10.1016/s0140-6736(16)30363-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.